Generic ruxolitinib cream vs Opzelura: what is the same, what is different, and what we do not know

Reviewed by Dr [PLACEHOLDER], dermatologist · Last reviewed [PLACEHOLDER date]

Opzelura is the original ruxolitinib cream, made by Incyte. Rutinib is a generic made in Bangladesh. They contain the same active ingredient at the same strength. That does not make them the same product, and you should know exactly where they differ.

Comparing generic ruxolitinib cream documents with Opzelura
Opzelura’s generic name is ruxolitinib. Ask for the batch certificate before you decide. Photo: Spencer Liao / Unsplash

01. What is the same

Three things are the same:

  • Active ingredient:ruxolitinib
  • Strength: 1.5% (15 mg per gram)
  • Form:a cream applied twice a day

02. Side by side

Where we could not verify something, it says so.

AttributeOpzeluraRutinib (Generic)
ManufacturerIncyte[PLACEHOLDER]
Where it is made[PLACEHOLDER]Bangladesh
Approval statusFDA: eczema age 2+, non-segmental vitiligo age 12+.
EU: non-segmental vitiligo with facial involvement, age 12+
Registered with DGDA, Bangladesh.
Not approved by FDA or EMA
Manufacturing standardFDA / EMA inspectedWHO-GMP [PLACEHOLDER certificate]
Inactive ingredients[PLACEHOLDER from label][PLACEHOLDER]
Pack sizes60 g, 100 g[PLACEHOLDER]
Clinical trialsTRuE-AD and TRuE-V programmesNone of its own [PLACEHOLDER: confirm]
Price per gram[PLACEHOLDER, source, date][PLACEHOLDER]

Open questions, stated plainly

01. How the cream base works Whether the cream base releases the drug into the skin in the same way. [PLACEHOLDER: manufacturer data, or say none is published].

02. Long-term results Long-term results with this specific generic. No published studies [PLACEHOLDER: confirm].

03. Heat during shipping How it performs in hot, humid storage over long shipping times. [PLACEHOLDER: stability data].

04. Why a generic can cost less

[PLACEHOLDER: factual explanation, for example no originator research costs and lower local manufacturing costs; no persuasive language].

05. How to decide

  1. Ask your dermatologist. Ask your dermatologist whether a generic is acceptable for you.
  2. Ask for the batch certificate. Ask us for the certificate of analysis for the batch you would receive.
  3. Compare the full monthly cost. Compare the full monthly cost, including shipping and duty.
  4. Decide what matters to you. Decide whether the open questions above matter to you.

Want to see the documents first? Ask us and we will send the certificate of analysis for the batch you would receive, before you pay.

Sources

  1. Opzelura prescribing information (revised 06/2026).
  2. Incyte press release, September 2025.
  3. Manufacturer information [PLACEHOLDER].